Trials / Completed
CompletedNCT00945945
A Study of Duloxetine in Patients With Osteoarthritis Knee Pain
A Phase 3b Study to Assess the Efficacy of Duloxetine 60 mg Once Daily Compared With Placebo on the Reduction of Pain Caused by Osteoarthritis of the Knee, in a 13-week, Double-blind, Randomized Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 424 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to determine if duloxetine 60 mg once daily (QD) reduces pain severity in patients with osteoarthritis (OA) knee pain compared with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine (DLX) | dose daily by mouth |
| DRUG | Placebo (PLA) | Placebo Comparator daily by mouth |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-07-24
- Last updated
- 2011-03-08
- Results posted
- 2011-03-08
Locations
26 sites across 8 countries: United States, Germany, Greece, Puerto Rico, Romania, Russia, Spain, Sweden
Source: ClinicalTrials.gov record NCT00945945. Inclusion in this directory is not an endorsement.